Does intermittent hypoxia in obstructive sleep apnea increase reactive oxygen species, impair mitochondrial function, and repeatedly activate the sympathetic nervous system?

Obstructive sleep apnea (OSA) exposes tissues to recurrent hypoxia–reoxygenation cycles, rather than a single sustained hypoxic insult. The claim is supported overall: these cycles promote oxidative stress, sympathetic surges, and—most directly in experimental models—mitochondrial dysfunction.

Oxidative and mitochondrial effects

• Recurrent reoxygenation is associated with increased ROS-related oxidative stress in adult OSA, including lipid, protein, and DNA oxidation and altered antioxidant defenses. Oxidative burden tracks nocturnal desaturation measures and time with oxygen saturation <90% more consistently than apnea–hypopnea index alone.
• Mechanistically, mitochondrial electron leakage during reoxygenation and NADPH-oxidase activation in leukocytes and vascular cells can generate superoxide. ROS then contribute to oxidative macromolecular damage. Reduced leukocyte ROS production with CPAP is consistent with reversibility of a hypoxia-linked process.
• Chronic intermittent-hypoxia models show impaired respiratory-chain complex II/IV activity, reduced membrane potential, respiration, calcium retention, and mitochondrial biogenesis regulators (PGC-1α/NRF1). Brain models show reduced state-3/state-4 respiration and neuronal apoptosis; cardiac effects were prevented by partial HIF-1α deletion. Direct human mitochondrial-functional evidence remains comparatively limited.

Autonomic and hemodynamic effects

• The human evidence for sympathetic activation is particularly direct. In healthy adults undergoing repetitive hypoxic apneas, muscle sympathetic nerve activity increased from 113±11 to 159±21 bursts/min.
• Hypoxemia (with associated hypercapnia) activates carotid-body chemoreceptors, increasing brainstem sympathetic outflow. This produces vasoconstriction and transient blood-pressure surges; repeated exposure may heighten chemoreflex sensitivity and sustain sympathetic tone.

Bottom line

• Intermittent hypoxia in OSA is a biologically and clinically credible driver of ROS-related injury and repeated sympathetic activation; mitochondrial impairment is strongly supported preclinically and plausibly contributes to downstream cardiovascular, neural, and metabolic consequences.